# AbbVie Inc. (ABBV) — Q3-2018 Earnings Results

**Report date:** 2018-11-02 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2018

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 0.81%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.14 | N/A | +5.34% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized the importance of their product pipeline despite current market challenges.

**Key quotes:**

> Management highlighted the strength of their pipeline and ongoing product performance.

> They acknowledged challenges in the market but expressed confidence in long-term growth.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

AbbVie's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 0.81% following the announcement, likely due to the lack of revenue details and guidance. Investors may be cautious given the absence of specific future projections.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2018_